BTSG — Brightspring Health Services Income Statement
0.000.00%
Last trade - 00:00
- $3.25bn
- $6.66bn
- $8.83bn
- 69
- 56
- 88
- 81
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,525 | 5,580 | 6,698 | 7,721 | 8,826 |
Cost of Revenue | |||||
Gross Profit | 834 | 1,049 | 1,248 | 1,354 | 1,434 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,462 | 5,415 | 6,464 | 7,533 | 8,679 |
Operating Profit | 63.3 | 165 | 234 | 188 | 147 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -104 | 26.2 | 68.9 | -45.8 | -177 |
Provision for Income Taxes | |||||
Net Income After Taxes | -71.1 | 21.2 | 51.3 | -54.2 | -157 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -72.4 | 20.8 | 49.8 | -53.9 | -155 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -72.4 | 20.8 | 49.8 | -53.9 | -155 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.037 | 0.343 | 0.496 | 0.136 | -0.372 |